Mode
Text Size
Log in / Sign up

Traditional Chinese Medicine modulates mitochondrial quality control to potentially address myocardial fibrosisTraditional Chinese Medicine May Help Protect Heart Tissue from Scarring Damage

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that TCM-mediated mitochondrial quality control may provide a basis for developing new anti-fibrotic therapies.

This systematic review examines the role of Traditional Chinese Medicine (TCM) monomers and formulas in addressing myocardial fibrosis. The scope of the review focuses on the impact of these treatments on mitochondrial-associated protein expression, gene transcription levels, and organelle ultrastructure.

The authors synthesize evidence indicating that TCM-mediated modulation of mitochondrial quality control (MQC) occurs in the context of myocardial fibrosis. These findings suggest that TCM components may influence cellular pathways relevant to cardiac tissue repair and protection. However, the evidence is derived from experimental models rather than human clinical trials.

Limitations of the current evidence include the lack of reported clinical trial data and the reliance on experimental models to establish mechanisms. While the review suggests a potential for developing contemporary anti-fibrotic therapeutics, the transition from experimental findings to clinical application is not yet established. The results should be interpreted as preliminary evidence for potential therapeutic targets in myocardial fibrosis.

How this fits prior evidence

This systematic review addresses a gap in the understanding of pharmacological mechanisms for myocardial fibrosis. It expands upon previous coverage of Traditional Chinese Medicine (TCM) in other conditions, such as its role in improving insomnia, its syndrome characteristics in bladder cancer, and its potential to modulate neuroimmunomodulatory pathways in multiple sclerosis. While previous findings established TCM's role in various physiological and clinical contexts, this review specifically focuses on the mitochondrial quality control mechanisms relevant to cardiac fibrosis.

Heart scarring, known as myocardial fibrosis, can make it hard for the heart to pump blood effectively. This condition often happens after a heart attack or due to long-term high blood pressure. When the heart muscle becomes scarred, it loses its ability to function normally.

Researchers looked at how specific ingredients in Traditional Chinese Medicine might help. These herbal formulas contain many different compounds that work together. The study focused on how these substances affect the tiny power plants inside our cells, which are called mitochondria.

By improving the quality and function of these power centers, the herbal treatments may help keep heart tissue healthy. The research suggests that these natural compounds could be used to develop new ways to treat heart damage and improve recovery for patients.

While more human studies are needed, the early evidence is promising. These treatments target multiple pathways at once to protect the heart. This approach could lead to new ways to manage heart health and prevent permanent damage to the heart muscle.

What this means for you:
Traditional Chinese Medicine may protect heart tissue by improving cell energy and reducing scarring.

Common questions

Is traditional Chinese medicine safe for heart scarring?

The review does not report any safety information, including side effects or serious adverse events. Without that data, it is impossible to say whether TCM is safe for people with heart scarring. Always talk to your doctor before trying any new treatment, especially if you have a heart condition.

Does this review prove TCM can treat myocardial fibrosis?

No. The review is based on experimental evidence, not human trials. It highlights potential multi-target advantages of TCM in fighting myocardial fibrosis, but it does not report patient outcomes, sample sizes, or follow-up data. This is early research, and much more study is needed before any conclusions can be drawn about treating people.

What is mitochondrial quality control and why does it matter for heart scarring?

Mitochondria are the power plants of your cells. Mitochondrial quality control is the process that keeps them healthy and working well. The review looks at how TCM might affect this process by changing mitochondrial-associated protein expression, gene transcription, and organelle structure. The hope is that better mitochondrial function could help reduce heart scarring, but this is still experimental.

How does TCM compare to current treatments for heart scarring?

The review does not compare TCM to any other treatment. It does not report a comparator group or head-to-head results. So there is no information on whether TCM works better, worse, or the same as existing options. If you are considering TCM for a heart condition, discuss it with your doctor first.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Myocardial fibrosis (MF), characterized by excessive collagen deposition, represents an inevitable pathological progression toward end-stage heart disease, underscoring the urgent clinical need for effective reversal strategies. In recent years, the mitochondrial quality control (MQC) system has emerged as a central regulatory hub for maintaining cardiac homeostasis, offering novel insights into the prevention and treatment of MF. This review bridges classical Traditional Chinese Medicine (TCM) therapeutic concepts with modern MQC mechanisms, primarily aiming to evaluate the intervention targets and efficacy of TCM monomers and formulas by detecting alterations in mitochondrial-associated protein expression, gene transcription levels, and organelle ultrastructure. By systematically reviewing experimental evidence of TCM-mediated MQC modulation, this paper highlights the multi-target and systematic advantages of TCM in combating MF, thereby injecting new momentum into the development of contemporary anti-MF therapeutics.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.